Cargando…
The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing
In the European Union and Canada, an Ann Arbor strain live attenuated influenza vaccine (LAIV) is approved for use in children aged 2–17 years, including those with mild to moderate asthma or prior wheezing. The safety and efficacy of LAIV versus trivalent inactivated influenza vaccine (TIV) in chil...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3456911/ https://www.ncbi.nlm.nih.gov/pubmed/22410646 http://dx.doi.org/10.1007/s10096-012-1595-9 |